• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors

tetano

Editor, Senior Moderator
Sci Rep


. 2023 Apr 29;13(1):7055.
doi: 10.1038/s41598-023-34305-6. Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors

Runchana Rungruangmaitree[SUP] 1 [/SUP], Sakao Phoochaijaroen[SUP] 2 [/SUP], Aunlika Chimprasit[SUP] 3 [/SUP], Patchreenart Saparpakorn[SUP] 3 [/SUP], Kusol Pootanakit[SUP] 1 [/SUP], Duangrudee Tanramluk[SUP] 4 5 [/SUP]



Affiliations
Abstract

With the rapid rate of SARS-CoV-2 Main protease (M[SUP]pro[/SUP]) structures deposition, a computational method that can combine all the useful structural features becomes crucial. This research focuses on the frequently occurring atoms and residues to find a generalized strategy for inhibitor design given a large amount of protein complexes from SARS-CoV in contrast to SARS-CoV-2 M[SUP]pro[/SUP]. By superposing large numbers of the ligands onto the protein template and grid box, we can analyse which part of the structure is conserved from position-specific interaction for both data sets for the development of pan-M[SUP]pro[/SUP] antiviral design. The difference in conserved recognition sites from the crystal structures can be used to determine specificity determining residues for designing selective drugs. We can display pictures of the imaginary shape of the ligand by unionising all atoms from the ligand. We also pinpoint the most probable atom adjustments to imitate the frequently found densities from the ligand atoms statistics. With molecular docking, Molecular Dynamics simulation, and MM-PBSA methods, a carbonyl replacement at the nitrile warhead (N5) of Paxlovid's Nirmatrelvir (PF-07321332) was suggested. By gaining insights into the selectivity and promiscuity regions for proteins and ligands, crucial residues are highlighted, and the antiviral design strategies are proposed.


 
Back
Top Bottom